Paolo Tarantino/X
May 17, 2025, 17:21
Paolo Tarantino Highlights Real-World Data on ADC Sequencing in Breast Cancer
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared Kelly Shanahan’s on X:
“Real world data suggest that chemo (cape, eribulin, taxanes) outperforms a second topo1 ADC after progression on T-DXd. Key question to address in breast oncology (and across oncology fields!). “
Quoting Kelly Shanahan’s, Director at Metavivor Research and Support, post on X:
“What about ADC sequencing?”
Insightful article about Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 12, 2025, 12:21
Aug 12, 2025, 12:18
Aug 12, 2025, 12:18
Aug 12, 2025, 12:12
Aug 12, 2025, 11:59
Aug 12, 2025, 11:29
Aug 12, 2025, 11:19
Aug 12, 2025, 11:14
Aug 12, 2025, 11:04
Aug 12, 2025, 11:03